Eli Lilly Says Weight-Loss Drug Sharply Reduces Diabetes Progression

Eli Lilly said preliminary data from a late-stage study showed its weight-loss drug significantly reduced the risk of progression to type 2 diabetes among adults with prediabetes and obesity or overweight.